Suppr超能文献

针对骨科疾病中的炎症和疼痛管理的肠道微生物组。

Targeting the Gut Microbiome for Inflammation and Pain Management in Orthopedic Conditions.

出版信息

Orthopedics. 2022 Sep-Oct;45(5):e226-e234. doi: 10.3928/01477447-20220608-07. Epub 2022 Jun 13.

Abstract

The human gut microbiome can be altered with probiotics, prebiotics, synbiotics, and anti-inflammatory foods and spices as part of an evidence-based strategy that targets inflammation and pain in common orthopedic conditions. Implementing these strategies avoids adverse effects associated with nonsteroidal anti-inflammatory drugs and minimizes the potential for opioid use. This review focuses exclusively on human trials studying the effects of gut microbiome alterations to address pain and inflammatory markers in common orthopedic conditions: osteoarthritis, rheumatoid arthritis, fractures/osteoporosis, and bone pain associated with chemotherapy. Individualized supplementation strategies can be further explored with the information in this review. [. 2022;45(5):e226-e234.].

摘要

人类肠道微生物组可以通过益生菌、益生元、合生菌以及抗炎食物和香料来改变,作为针对常见骨科疾病中的炎症和疼痛的循证策略的一部分。实施这些策略可以避免与非甾体抗炎药相关的不良反应,并最大限度地减少阿片类药物的使用。本综述专门关注人类试验,研究肠道微生物组改变对常见骨科疾病中的疼痛和炎症标志物的影响:骨关节炎、类风湿关节炎、骨折/骨质疏松症以及与化疗相关的骨痛。本综述中的信息可以进一步探讨个体化补充策略。[. 2022;45(5):e226-e234.].

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验